Literature DB >> 26296486

Magnetic Resonance Imaging in the Diagnosis, Staging, and Surveillance of Cervical Carcinoma.

Catherine Devine1, Carly Gardner2, Tara Sagebiel3, Priya Bhosale3.   

Abstract

Cervical carcinoma remains a common gynecologic malignancy. Magnetic resonance imaging is a useful and accurate tool in the diagnosis, staging, and follow-up of cervical carcinoma. This article describes the optimal techniques for magnetic resonance evaluation of the cervix, illustrates the role of magnetic resonance imaging in patients with known or indicated cervical carcinoma, and describes key aspects of staging and management of cervical carcinoma.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2015        PMID： 26296486     DOI： 10.1053/j.sult.2015.05.004

Source DB:  PubMed          Journal:  Semin Ultrasound CT MR        ISSN： 0887-2171            Impact factor:   1.875


  4 in total

1.  Tumor growth patterns on magnetic resonance imaging and treatment outcomes in patients with locally advanced cervical cancer treated with definitive radiotherapy.

Authors:  Shintaro Tsuruoka; Masaaki Kataoka; Yasushi Hamamoto; Akifumi Tokumasu; Kotaro Uwatsu; Hiromitsu Kanzaki; Noriko Takata; Hirofumi Ishikawa; Ayaka Ouchi; Teruhito Mochizuki
Journal:  Int J Clin Oncol       Date:  2019-05-11       Impact factor: 3.402

2.  Hybrid MRI guided radiotherapy in locally advanced cervical cancer: Case report of an innovative personalized therapeutic approach.

Authors:  L Boldrini; G Chiloiro; A Pesce; A Romano; S Teodoli; L Placidi; M Campitelli; M A Gambacorta; V Valentini
Journal:  Clin Transl Radiat Oncol       Date:  2019-10-25

3.  Value of diffusion-weighted imaging in preoperative evaluation and prediction of postoperative supplementary therapy for patients with cervical cancer.

Authors:  Liying Liu; Shuo Wang; Tao Yu; Haoyan Bai; Jingyu Liu; Danbo Wang; Yahong Luo
Journal:  Ann Transl Med       Date:  2022-01

4.  Application Value of Real-Time Ultrasonic Elastograph with Serum Human Epididymis Protein 4, Interleukin-33, and Carbohydrate Antigen 153 in Diagnosis of Early Cervical Cancer.

Authors:  Maoping Guo; Lingling Liang; Litao Wu; Daolin Xie; Jian Li
Journal:  J Healthc Eng       Date:  2022-04-12       Impact factor: 3.822
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.